2023
- Is the use of piperacillin/tazobactam associated with risk of acute kidney injury?
- What are institutional perioperative practices for patients with alpha-gal allergy?
- What is the role of ketamine in the management of status epilepticus?
- What are the latest updates and recommendations on vaccination against COVID-19?
- Can thiazide diuretics cause increases in serum glucose?
- What efficacy data are available on the use of tirzepatide for obesity?
- Do data support the use of commercially available fecal microbiota transplantation products in managing recurrent Clostridioides difficile infection?
- Is there a risk of intraoperative aspiration with the use of GLP-1 receptor agonists?
- What data exists on the use of collagenase clostridium histolyticum (CCH) for the treatment of Peyronie’s disease?
- Does Granulocyte Colony Stimulating Factor Increase the Risk of Bleomycin Induced Lung Injury?
- A Summary of the 2023 American Geriatrics Society Updated Beers Criteria® for Potentially Inappropriate Medication Use in the Elderly
- What are current best practices on holding metformin prior to and post contrast administration?
- What literature supports the use of low-dose rifaximin in patients with hepatic encephalopathy?
- What data exists on the use of buprenorphine and buprenorphine-naloxone for the treatment of kratom withdrawal?
- Is there a preference between topical natamycin and topical voriconazole for first-line treatment of fungal keratitis?
- What evidence supports the use of ketamine in pain management of vaso-occlusive episodes in patients with sickle cell disease?
- What is the evidence for using greater than the FDA recommended dose of clobazam?
- Does the literature support the use of doxycycline for post-exposure prophylaxis against sexually transmitted infections?
- What evidence supports the use of neurokinin‐1 receptor antagonists for gastroparesis-related nausea and vomiting?
- What is the optimal duration of antibiotics for complicated UTI in a male patient?
- What is the update on long-term safety evidence with proton pump inhibitor use?
- Is weight loss sustained after discontinuation of glucagon-like peptide 1 receptor agonists for obesity?
- What information is available regarding the safety of Janus kinase (JAK) inhibitors in patients with rheumatoid arthritis?
- What evidence is available supporting the use of vitamin D in the treatment of asthma?
- What clinical evidence supports the use of lecanemab for Alzheimer disease?
- What considerations should pharmacists make in relation to teplizumab use in patients with type 1 diabetes mellitus?
- What data are available for sublingual dexmedetomidine in the treatment of acute agitation related to schizophrenia or bipolar disorder?
- Should allopurinol be given simultaneously with rasburicase for tumor lysis syndrome?
- Update: Can the intravenous formulation of vitamin K be administered orally?
- What literature is available on the use of enteral immunoglobulin for the treatment of norovirus enteritis?
- What data supports the use of alteplase 1 mg versus 2 mg for catheter occlusions?
- Does the available data support the use of liposomal bupivacaine for analgesia during vasectomy and vasectomy reversal procedures?
- Update: What evidence supports rectal indomethacin for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis?
- What recent updates are available to guide decisions on use of immunosuppressant antirheumatic drugs perioperatively for orthopedic procedures?
- What data are available for systemic tenecteplase in submassive pulmonary embolism?
- What are current guideline recommendations for use of terlipressin in hepatorenal syndrome?